333pcirculating Tumor Cell Count at Baseline Is an Independent Prognostic Factor from Pathological Complete Response among Patients Treated for Primary Inflammatory Her2-positive Breast Cancer: Survival Results of the Beverly-2 Study.
J. Y. Pierga
Annals of oncology : official journal of the…
View on PubMed
Abstract & Figures
Sorry, we couldn't extract an abstract for this paper.
ERBB2 protein, human
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics